Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nikole Wollerstein who wrote (342)	2/3/2006 12:48:38 PM
From: Pluvia	Read Replies (2) of 377

I do not get it :I thought SIMPADICO trial failed to show dif with placebo... Do you understand what is going on? Understand - no. Simply guessing. Guess 1. We do not think they would make an effort to PR bad results; Guess 2. We think they know the results as they likely were required to submit an abstract to the conference for approval to be allowed to present... Guess 3. The flip side; the results are bad and they're only presenting because they're required to do so to comply with disclosure requirements. We think if this were true they would do it with less pr, but we could be dead wrong. Regardless of PAD results, we have HIGH confidence CHF results will be VERY good.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next